A long-acting HIV drug arrives in Zimbabwe for some at highest risk
22 février 2026 à 05:03
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year

© Copyright 2026 The Associated Press. All rights reserved.